Cointime

IMPACT Therapeutics

company

About

IMPACT Therapeutics is a China based Company.

  • 1 - 10

Highlights

Total Funding Amount
$90M
Funding Rounds
5
Investors
6

Details

Last Funding Type
Series C
Last Funding Money Raised
$50M
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jun 1, 2009
Number Of Employee
1 - 10
Operating Status
Active

IMPACT Therapeutics is dedicated to the development of similar drugs to treat cancer have independent intellectual property rights and other diseases of the best (best-in-class) of new drugs and its commercialization. The company's senior management team of experienced and professional background complementary and have accumulated more than four decades of experience in drug development and management. General Manager and Chief Scientific Officer Field are an expert in pharmacology and biology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$90M
IMPACT Therapeutics has raised a total of $90M in funding over 2 rounds. Their latest funding was raised on Mar 14, 2022 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 14, 2022 Series D — 4 — — Detail
Dec 1, 2020 Series C $50M 4 — — Detail
Aug 3, 2018 Series C $30M 1 — — Detail
Feb 22, 2016 Series B $10M 2 — — Detail
Jul 7, 2014 Series A — 1 Lilly Asia Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
6
IMPACT Therapeutics is funded by 6 investors. China Summit Capital and Bestride are the most recent investors.
Investor Name Lead Investor Funding Round
China Summit Capital — Series D
Bestride — Series D
CCBT Private Equity — Series D
Lilly Asia Ventures — Series D
Zhenji Capital — Series C
AJ Asset Management — Series C
Cointime
เนื้อหา
บริษัท